Laura Prendergast
Stock Analyst at Stifel
(4.78)
# 113
Out of 5,147 analysts
17
Total ratings
56.25%
Success rate
74.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OLMA Olema Pharmaceuticals | Initiates: Buy | $48 | $24.20 | +98.35% | 1 | Feb 11, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Initiates: Buy | $23 | $10.03 | +129.31% | 1 | Feb 11, 2026 | |
| RVMD Revolution Medicines | Maintains: Buy | $85 → $170 | $102.02 | +66.63% | 4 | Jan 22, 2026 | |
| TNGX Tango Therapeutics | Initiates: Buy | $15 | $11.14 | +34.65% | 1 | Dec 4, 2025 | |
| FHTX Foghorn Therapeutics | Initiates: Buy | $12 | $5.68 | +111.27% | 1 | Dec 4, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $115 → $135 | $101.95 | +32.42% | 2 | Nov 17, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Buy | $8 | $2.47 | +223.89% | 2 | Oct 16, 2025 | |
| ERAS Erasca | Initiates: Buy | $4 | $13.66 | -70.72% | 2 | Oct 16, 2025 | |
| COGT Cogent Biosciences | Initiates: Hold | $16 | $38.85 | -58.82% | 1 | Oct 16, 2025 | |
| NKTX Nkarta | Upgrades: Strong Buy | $16 | $2.70 | +492.59% | 2 | Aug 14, 2024 |
Olema Pharmaceuticals
Feb 11, 2026
Initiates: Buy
Price Target: $48
Current: $24.20
Upside: +98.35%
BridgeBio Oncology Therapeutics
Feb 11, 2026
Initiates: Buy
Price Target: $23
Current: $10.03
Upside: +129.31%
Revolution Medicines
Jan 22, 2026
Maintains: Buy
Price Target: $85 → $170
Current: $102.02
Upside: +66.63%
Tango Therapeutics
Dec 4, 2025
Initiates: Buy
Price Target: $15
Current: $11.14
Upside: +34.65%
Foghorn Therapeutics
Dec 4, 2025
Initiates: Buy
Price Target: $12
Current: $5.68
Upside: +111.27%
Nuvalent
Nov 17, 2025
Maintains: Buy
Price Target: $115 → $135
Current: $101.95
Upside: +32.42%
Black Diamond Therapeutics
Oct 16, 2025
Reinstates: Buy
Price Target: $8
Current: $2.47
Upside: +223.89%
Erasca
Oct 16, 2025
Initiates: Buy
Price Target: $4
Current: $13.66
Upside: -70.72%
Cogent Biosciences
Oct 16, 2025
Initiates: Hold
Price Target: $16
Current: $38.85
Upside: -58.82%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $2.70
Upside: +492.59%